These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 31940000)

  • 1. A Multicenter Cross-Sectional Study and Systematic Review of Necrobiotic Xanthogranuloma With Proposed Diagnostic Criteria.
    Nelson CA; Zhong CS; Hashemi DA; Ashchyan HJ; Brown-Joel Z; Noe MH; Imadojemu S; Micheletti RG; Vleugels RA; Wanat KA; Rosenbach M; Mostaghimi A
    JAMA Dermatol; 2020 Mar; 156(3):270-279. PubMed ID: 31940000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xanthoma-like Skin Changes in an Elderly Woman with a Normal Lipid Profile.
    Nockowski P; Woźniak Z; Reich A; Maj J
    Acta Dermatovenerol Croat; 2017 Jul; 25(2):167-169. PubMed ID: 28871936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of necrobiotic xanthogranuloma - a systematic review.
    Miguel D; Lukacs J; Illing T; Elsner P
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):221-235. PubMed ID: 27436448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies.
    Higgins LS; Go RS; Dingli D; Kumar SK; Rajkumar SV; Dispenzieri A; Buadi FK; Lacy MQ; Lust JA; Kapoor P; Leung N; Lin Y; Kourelis TV; Gertz MA; Kyle RA; Gonsalves WI
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):447-52. PubMed ID: 27238425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of refractory necrobiotic xanthogranulomas with extracorporeal photopheresis and intravenous immunoglobulin.
    Liszewski W; Wisniewski JD; Safah H; Boh EE
    Dermatol Ther; 2014; 27(5):268-71. PubMed ID: 24910296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necrobiotic xanthogranuloma: a 30-year single-center experience.
    Hilal T; DiCaudo DJ; Connolly SM; Reeder CB
    Ann Hematol; 2018 Aug; 97(8):1471-1479. PubMed ID: 29568990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectacular skin nodules: cutaneous necrobiotic xanthogranuloma without paraproteinemia.
    Kadakia S; Nadkarni N; Sonavane S; Ghate S
    Indian J Dermatol; 2012 Sep; 57(5):396-8. PubMed ID: 23112364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necrobiotic Xanthogranuloma With Associated Monoclonal Gammopathy Presenting as an Eyelid Nodule.
    Punyamurthy NT; Tjahjono LA; Harris GJ; Wanat KA
    Ophthalmic Plast Reconstr Surg; 2023 Sep-Oct 01; 39(5):e148-e150. PubMed ID: 37279015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relapsing, therapy refractory episcleritis, paraproteinemia and cutaneous-subcutaneous nodules on arm and hip: manifestations of a necrobiotic xanthogranuloma (NXG)].
    Siepmann K; Metzler G; Kötter I; Zierhut M; Scherwitz Ch
    Klin Monbl Augenheilkd; 2004 Jun; 221(6):498-502. PubMed ID: 15236112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complete remission of necrobiotic xanthogranuloma after disappearance of monoclonal immunoglobulin induced by bortezomib, lenalidomid and dexamethasone].
    Adam Z; Pour L; Řehák Z; Dvořáková K; Koukalová R; Feit J; Kameník P; Krejčí M; Štork M; Krejčí M; Sandecká V; Boichuk I; Král Z
    Vnitr Lek; 2021; 67(6):352-356. PubMed ID: 35459378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necrobiotic xanthogranuloma without a monoclonal gammopathy.
    Seastrom S; Bookout A; Hogan DJ
    Cutis; 2014 Dec; 94(6):293-6. PubMed ID: 25566570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy.
    Szalat R; Pirault J; Fermand JP; Carrié A; Saint-Charles F; Olivier M; Robillard P; Frisdal E; Villard EF; Cathébras P; Bruckert E; Chapman MJ; Giral P; Guerin M; Lesnik P; Le Goff W
    J Intern Med; 2014 Sep; 276(3):269-84. PubMed ID: 24428816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necrobiotic xanthogranuloma: a review of 17 cases with emphasis on clinical and pathologic correlation.
    Wood AJ; Wagner MV; Abbott JJ; Gibson LE
    Arch Dermatol; 2009 Mar; 145(3):279-84. PubMed ID: 19289757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solitary necrobiotic xanthogranuloma of an upper extremity in association with multiple myeloma.
    Bain EE; Meehan SA; Hale EK
    J Drugs Dermatol; 2014 May; 13(5):598-600. PubMed ID: 24809886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Necrobiotic xanthogranuloma.
    Fernández-Herrera J; Pedraz J
    Semin Cutan Med Surg; 2007 Jun; 26(2):108-13. PubMed ID: 17544963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periorbital Necrobiotic Xanthogranuloma Successfully Treated with Intravenous Immunoglobulin.
    Olson RM; Harrison AR; Maltry A; Mokhtarzadeh A
    Case Rep Ophthalmol; 2018; 9(1):70-75. PubMed ID: 29643785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necrobiotic Xanthogranuloma as the Presenting Manifestation of Smouldering Myeloma.
    Makkar N; Niyas VKM; Swain S; Sethi P; Nischal N; Agarwal S; Ramam M; Wig N
    J Assoc Physicians India; 2019 Mar; 67(3):87-88. PubMed ID: 31304718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of necrobiotic xanthogranuloma with total glucosides of paeony.
    Li S; Chen AJ; Fang S; Li H
    Dermatol Ther; 2014; 27(5):304-6. PubMed ID: 24774012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necrobiotic xanthogranuloma of the extremities with paraproteinemia and without periorbital involvement at presentation.
    Hashemi P; Rashidi A; Chapas AM; Balfour EM
    Cutis; 2012 Jan; 89(1):41-4. PubMed ID: 22439311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrobiotic xanthogranuloma with lambda paraproteinemia: case report of successful treatment with melphalan and prednisone.
    Criado PR; Vasconcellos C; Pegas JR; Lopes LF; Ramos CF; Tebcherani AJ; Valente NY
    J Dermatolog Treat; 2002 Jun; 13(2):87-9. PubMed ID: 12060508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.